Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy

BACKGROUND: Sarcopenia, which is defined as the loss of skeletal muscle mass, has been identified as a poor prognostic factor for cancer patients. This study sought to elucidate the effects of sarcopenia on the outcomes of advanced non-small cell lung cancer (NSCLC) patients receiving salvage anti-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yixing, Chen, Ping, Huang, Jinsheng, Liu, Minghui, Peng, Dingsheng, Li, Zichun, Chen, Tao, Hong, Shaodong, Zhou, Yixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756219/
https://www.ncbi.nlm.nih.gov/pubmed/35071495
http://dx.doi.org/10.21037/atm-21-6578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756219/
https://www.ncbi.nlm.nih.gov/pubmed/35071495
http://dx.doi.org/10.21037/atm-21-6578

Ejemplares similares